{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-1167-0017", "FDA", "FDA-2014-D-1167", "Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability; Correction", "Notice", "Correction", "2017-11-17T05:00:00Z", 2017, 11, "2017-11-17T05:00:00Z", null, "2017-11-17T20:10:11Z", "2017-24948", 0, 0, "0900006482c8a43d"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-1167-0017"], "units": {}, "query_ms": 0.4357070429250598, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}